References
- Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361.
- Alamanos Y , Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005;4(3):130–136.
- McInnes IB , Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–2219.
- Majithia V , Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007;120(11):936–939.
- Choy EH , Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344(12):907–916.
- Baecklund E , Iliadou A , Askling J , et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54(3):692–701.
- Bjarnason I , So A , Levi AJ , et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. The Lancet. 1984;324(8413):1171–1174.
- Bartok B , Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255.
- Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 1996;39(11):1781–1790.
- Firestein G , Alvaro-Gracia J , Maki R , et al. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol. 1990;144(9):3347–3353.
- Källberg H , Padyukov L , Plenge RM , et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet. 2007;80(5):867–875.
- Nakasa T , Miyaki S , Okubo A , et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58(5):1284–1292.
- Stanczyk J , Pedrioli DML , Brentano F , et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001–1009.
- Stanczyk J , Ospelt C , Karouzakis E , et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011;63(2):373–381.
- Nakamachi Y , Kawano S , Takenokuchi M , et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2009;60(5):1294–1304.
- Xiong Q , Wu S , Wang J , et al. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell Biosci. 2017;7(1):16.
- Song L , Duan P , Gan Y , et al. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma. Braz J Med Biol Res. 2017;50(5):e6359
- Zhao P , Ma W , Hu Z , et al. Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4. J Endocrinol Invest. 2018;41(10):1165–1172.
- Lee SY , Kwok SK , Son HJ , et al. IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res Ther. 2013;15(1):R31.
- Lao M , Shi M , Zou Y , et al. Protein inhibitor of activated STAT3 regulates migration, invasion, and activation of fibroblast-like synoviocytes in rheumatoid arthritis. J Immunol. 2016 ;196(2):596–606.
- Kim SK , Park KY , Yoon WC , et al. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis. Joint Bone Spine. 2011;78(5):471–477.
- Nowell MA , Williams AS , Carty SA , et al. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol. 2009;182(1):613–622.
- Krause A , Scaletta N , Ji J-D , et al. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol. 2002;169(11):6610–6616.
- Katoh M , Katoh M. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer. Int J Mol Med. 2007;19(2):273–278.
- Brand DD , Latham KA , Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269–1275.
- Li J , Wan Y , Guo Q , et al. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12(3):R81.
- Furer V , Greenberg JD , Attur M , et al. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol. 2010;136(1):1–15.
- Pauley KM , Cha S. miRNA-146a in rheumatoid arthritis: a new therapeutic strategy. Immunotherapy. 2011;3(7):829–831.
- Duroux-Richard I , Pers Y-M , Fabre S , et al. Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis. Mediators Inflamm. 2014;2014:342524.
- Qu Y , Wu J , Deng J-X , et al. MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway. Oncotarget. 2016;7(45):74217–74226.
- Nakagawa S , Toritsuka Y , Wakitani S , et al. Bone marrow stromal cells contribute to synovial cell proliferation in rats with collagen induced arthritis. J Rheumatol. 1996;23(12):2098–2103.
- Isomäki P , Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 1997;29(6):499–507.
- Mangge H , Kenzian H , Gallistl S , et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 1995;38(2):211–220.
- Paramalingam SS , Thumboo J , Vasoo S , et al. In vivo pro-and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann-Acad Med Singapore. 2007;36(2):96.
- Gao W , McCormick J , Connolly M , et al. Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Ann Rheum Dis. 2015;74(6):1275–1283.
- Liu J , Fei D , Xing J , et al. MicroRNA-29a inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by repressing STAT3. Biomed Pharmacother. 2017;96:173–181.